Kalymin

Pyridostigmine bromide, the active ingredient in Kalymin, is a cholinesterase inhibitor presented as an oral tablet for oral use. It is employed to improve muscle strength in myasthenia gravis and to reverse the effects of non‑depolarizing neuromuscular blocking agents. GNH USA supplies Kalymin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Pyridostigmine bromide is used in conditions that involve impaired neuromuscular transmission. - Myasthenia gravis: enhances skeletal muscle strength by increasing acetylcholine availability. - Reversal of neuromuscular blockade: restores normal neuromuscular function after administration of non‑depolarizing blockers. - Myasthenic crisis: provides supportive therapy to improve respiratory muscle performance during acute exacerbations.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: increased bowel movements. - Abdominal cramps: discomfort in the stomach area. - Increased salivation: excess oral secretions. - Sweating: heightened perspiration. - Muscle cramps: involuntary muscle tightening.

Serious or Rare Side Effects: - Cholinergic crisis: severe muscle weakness and respiratory failure. - Bradycardia: markedly slow heart rate. - Bronchospasm: narrowing of the airways causing breathing difficulty. - Seizures: uncontrolled electrical activity in the brain. - Anaphylaxis: life‑threatening allergic reaction.

Before prescribing pyridostigmine bromide, clinicians should consider several safety measures. - Renal impairment: adjust dose because the drug is renally excreted. - Asthma or COPD: monitor for bronchospasm due to cholinergic effects. - Cardiac conditions: observe for bradycardia or heart block. - Concomitant anticholinergic therapy: may reduce efficacy, requiring dose review. - Known hypersensitivity: avoid use if allergic reactions have occurred. - Store at ambient temperature: keep in the original pack, protect from moisture.

Pyridostigmine bromide can alter the activity of several other medicines.

Major Interactions (Avoid): - Non‑depolarizing neuromuscular blockers: may potentiate blockade, risking prolonged paralysis. - Other cholinesterase inhibitors: can cause excessive cholinergic activity. - Beta‑blockers: increase risk of bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., atropine): may diminish therapeutic effect. - Diuretics that cause hypokalemia: can exacerbate muscle weakness. - Magnesium supplements: may enhance neuromuscular blockade.